Detalhe da pesquisa
1.
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.
Clin Infect Dis
; 75(4): 682-689, 2022 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34849645
2.
Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020.
Monaldi Arch Chest Dis
; 91(1)2021 Jan 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33470088
3.
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks.
Tuberculosis (Edinb)
; 144: 102462, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38070353
4.
Combined cerebrospinal fluid metabolomic and cytokine profiling in tuberculosis meningitis reveals robust and prolonged changes in immunometabolic networks.
medRxiv
; 2023 Jun 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37425849
5.
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid.
medRxiv
; 2023 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38168338
6.
Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis.
Front Pharmacol
; 13: 1048653, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36578553
7.
Long term outcomes of patients with tuberculous meningitis: The impact of drug resistance.
PLoS One
; 17(6): e0270201, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35749509